rs770993927
Variant summary
Our verdict is Benign. Variant got -12 ACMG points: 1P and 13B. PP2BP4BP6_Very_StrongBS2
The NM_001271.4(CHD2):c.4483G>A(p.Val1495Met) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000421 in 1,614,208 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. V1495V) has been classified as Likely benign.
Frequency
Consequence
NM_001271.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -12 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CHD2 | NM_001271.4 | c.4483G>A | p.Val1495Met | missense_variant | 35/39 | ENST00000394196.9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CHD2 | ENST00000394196.9 | c.4483G>A | p.Val1495Met | missense_variant | 35/39 | 5 | NM_001271.4 | P1 | |
CHD2 | ENST00000626874.2 | c.4483G>A | p.Val1495Met | missense_variant | 35/38 | 1 | |||
CHD2 | ENST00000630813.1 | n.309G>A | non_coding_transcript_exon_variant | 2/2 | 2 | ||||
CHD2 | ENST00000625662.3 | c.*654G>A | 3_prime_UTR_variant, NMD_transcript_variant | 31/35 | 5 |
Frequencies
GnomAD3 genomes ? AF: 0.000191 AC: 29AN: 152218Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000358 AC: 9AN: 251354Hom.: 0 AF XY: 0.0000221 AC XY: 3AN XY: 135866
GnomAD4 exome AF: 0.0000267 AC: 39AN: 1461872Hom.: 0 Cov.: 32 AF XY: 0.0000248 AC XY: 18AN XY: 727234
GnomAD4 genome ? AF: 0.000190 AC: 29AN: 152336Hom.: 0 Cov.: 33 AF XY: 0.000188 AC XY: 14AN XY: 74492
ClinVar
Submissions by phenotype
not provided Benign:2
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Oct 01, 2023 | CHD2: BS2 - |
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Apr 21, 2020 | - - |
Inborn genetic diseases Benign:1
Benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 10, 2020 | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Developmental and epileptic encephalopathy 94 Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Invitae | Dec 18, 2023 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at